seen from United States
seen from India
seen from Brazil
seen from United States
seen from Brazil
seen from Brazil
seen from United States
seen from Venezuela
seen from United States
seen from Saudi Arabia
seen from Canada
seen from Indonesia
seen from United States
seen from Japan
seen from United States
seen from Ecuador
seen from China
seen from Iraq
seen from Spain
seen from Russia
It is estimated that 11,000 new cases of GBM are diagnosed every year and the five-year survival rate is between 5 and 10%.
Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Medical Device Network lists seven promising liquid biopsy companies participating in the ESMO Congress 2019 conference being held in September.
Liquid biopsy, a minimally invasive cancer diagnostic tool, has gained momentum in the last five years due to its advantages over the archaic painful procedure of solid tumour biopsy.
Bio-Rad Laboratories has reported data from three clinical studies using its ddPCR-powered liquid biopsy to track cancer progression and therapy response.
Clinical diagnostic solutions maker Bio-Rad Laboratories has reported data from three clinical studies using its Droplet Digital PCR (ddPCR) powered liquid biopsy to track cancer progression and assess therapy response.
